Response to cyclosporine A in a patient with pure red cell aplasia due to antierythropoietin-α antibodies

Seminars in Dialysis

Volumn 19, Issue 3, 2006, Pages 251-255

  Fraer, Mony ^b   Campbell, Adam ^b   Sawaya, B Peter ^a,b  

^a UKMC ^*  (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIANEMIC AGENT; ANTIINFLAMMATORY AGENT; AUTOANTIBODY; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; PREDNISONE; RECOMBINANT ERYTHROPOIETIN;

ARTICLE; BLOOD; CASE REPORT; CHEMICALLY INDUCED DISORDER; CHRONIC KIDNEY FAILURE; DRUG COMBINATION; DRUG HYPERSENSITIVITY; HUMAN; IMMUNOLOGY; MALE; MIDDLE AGED; PATHOLOGY; PURE RED CELL ANEMIA; RENAL REPLACEMENT THERAPY;

ANTI-INFLAMMATORY AGENTS; AUTOANTIBODIES; CYCLOSPORINE; DRUG HYPERSENSITIVITY; DRUG THERAPY, COMBINATION; EPOETIN ALFA; HEMATINICS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PREDNISONE; RED-CELL APLASIA, PURE; RENAL DIALYSIS;

EID: 33646671469     PISSN: 08940959     EISSN: 1525139X     Source Type: Journal    
DOI: 10.1111/j.1525-139X.2006.00163.x     Document Type: Article

References (33)

1. Mercadal L, Sutton L, Casadevall N, Bagnis C, Jacobs C: Immunological reaction against erythropoietin causing red cell aplasia. Nephrol Dial Transplant 17: 943, 2002
2. Tolman C, Duja S, Richardson D, Rashid R, McVerry A, Mooney A, Baker R, Will E: Four cases of pure red cell aplasia secondary to epoetin B, with strong temporal relationships. Nephrol Dial Transplant 19: 2133 2136, 2004
3. Peces R, de la Torre M, Alcazar R, Urra JM: Antibodies against recombinant human erythropoietin in a patient with erythropoietin resistant anemia. N Engl J Med 335: 523 524, 1996
4. Casadevall N, Nataf J, Viron B, Kolta A, Kiladjian JJ, Martin-Dupont P, Michaud P, Papo T, Ugo V, Teyssandier I, Varet B, Mayeux P: Pure red-cell aplasia and antierythropoietin antibodies in patients treated with recombinant erythropoietin. N Engl J Med 346: 469 475, 2002
5. Bennett CL, Luminari S, Nissenson AR, Tallman MS, Klinge SA, McWilliams N, McKoy JM, Kim B, Lyons EA, Trifilio SM, Raisch DW, Evens AM, Kuzel TM, Schumock GT, Belknap SM, Locatelli F, Rossert J, Casadevall N: Pure red cell aplasia and epoetin therapy. N Engl J Med 351: 1403 1408, 2004
6. Evens AM, Bennett CL, Luminari S: Epoetin-induced pure red-cell aplasia (PRCA): preliminary results from the research on adverse drug events and reports (RADAR) group. Best Pract Res Clin Haematol 18: 481 489, 2005
7. Macdougall IC: Antibody-mediated pure red cell aplasia (PRCA): epidemiology, immunogenicity and risks. Nephrol Dial Transplant 20 suppl 4 iv9 iv15, 2005
8. Cournoyer D, Toffelmire EB, Wells GA, Barber DL, Barrett BJ, Delage R, Forrest DL, Gagnon RF, Harvey EA, Laneuville P, Patterson BJ, Poon MC, Posen GA, Messner HA, Canadian PRCA Focus Group: Anti-erythropoietin antibody-mediated pure red cell aplasia after treatment with recombinant erythropoietin products: recommendations for minimization of risk. J Am Soc Nephrol 15: 2728 2734, 2004
9. Casadevall N: Antibodies against rHuEpo: native and recombinant. Nephrol Dial Transplant 17 suppl 5 42 47, 2002
10. Eckardt K-U, Casadevall N: Pure red-cell aplasia due to anti-erythropoietin antibodies. Nephrol Dial Transplant 18: 865 869, 2003
11. Krantz SB: Pure red-cell aplasia. N Engl J Med 291: 345 350, 1974
12. Boven K, Stryker S, Knight J, Thomas A, Van Regenmortel M, Kemeny DM, Power D, Rossert J, Casadevall N: The increased incidence of pure red cell aplasia with an Eprex formulation in uncoated rubber stopper syringes. Kidney Int 67: 2346 2353, 2005
13. Stravitz RT, Chung H, Sterling RK, Luketic VA, Sanyal AJ, Price AS, Purrington A, Shiffman ML: Antibody-mediated pure red cell aplasia due to epoetin alfa during antiviral therapy of chronic hepatitis C. Am J Gasteroenterol 100: 1415 1419, 2005
14. Verhelst D, Rossert J, Casadevall N, Kruger A, Eckardt KU, Macdougall IC: Treatment of erythropoietin-induced pure red cell aplasia: a retrospective study. Lancet 363: 1768 1771, 2004
15. Tacey R, Greway A, Smiell J, Power D, Kromminga A, Daha M, Casadevall N, Kelley M: The detection of antierythropoietin antibodies in human serum and plasma. Part I. Validation of the protocol for a radioimmunoprecipitation assay. J Immunol Meth 283: 317 329, 2003
16. Dessypris EN: The biology of pure red cell aplasia. Semin Hematol 28: 275 284, 1991
17. de Klerk G, Rosengarten PC, Vet RJ, Goudsmit R: Serum erythropoietin titers in anemia. Blood 58: 1164 1170, 1981
18. Asari A, Gokal R: Pure red cell aplasia secondary to epoetin alpha responding to darbepoetin alpha in a patient on peritoneal dialysis. J Am Soc Nephrol 15: 2204 2207, 2004
19. Schonholzer C, Keusch G, Nigg L, Robert D, Wauters JP: High prevalence in Switzerland of pure red-cell aplasia due to antierythropoietin antibodies in chronic dialysis patients: report of five cases. Nephrol Dial Transplant 19: 2121 2125, 2004
20. Weber G, Gross J, Kromminga A, Loew HH, Eckardt K-U: Allergic skin and systemic reactions in a patient with pure red cell aplasia and anti-erythropoietin antibodies challenged with different epoetins. J Am Soc Nephrol 13: 2381 2383, 2002
21. Asari A, Gokal R: Pure red cell aplasia secondary to epoetin alpha responding to darbepoetin alpha in a patient on peritoneal dialysis. J Am Soc Nephrol 15: 2204 2207, 2004
22. Macdougall IC, Roche A, Rossert J, Casadevall N, Francois P, Kemeny DM: Case report: re-challenging patients who developed pure red cell aplasia with epoetin: can it be done. Nephrol Dial Transplant 19: 2901 2905, 2004
23. Panchapakesan U, Austin SK, Shafransky A, Lawrence JA, Savdie E: Brief communication: recovery of pure red cell aplasia secondary to antierythropoietin after cessation of recombinant human erythropoietin. Intern Med J 33: 468 471, 2003
24. Summers SA, Matijevic A, Almond MK: Successful re-introduction of recombinant human erythropoietin following antibody induced pure red cell aplasia. Nephrol Dial Transplant 19: 2137 2179, 2004
25. Vartia A, Asola MR, Tertti R, Kunelius P, Metsarinne KP: Two haemodialysis patients with epoetin alfa-induced pure red cell aplasia recovered despite treatment with another epoetin preparation. Nephrol Dial Transplant 19: 1313 1316, 2004
26. Mandreoli M, Finelli C, Lopez A, Ascani S, Vianelli N, Baccarani M, Santoro A: Successful resumption of epoetin alfa after rituximab treatment in a patient with pure red cell aplasia. Am J Kidney Dis 44: 757 761, 2004
27. Alonso Melgar A, Melgosa Hijosa M, Pardo de la Vega R, Garcia Meseguer C, Navarro Torres M: Antierythropoietin antibody-induced pure red cell aplasia: posttransplant evolution. Pediatr Nephrol 19: 1059 1061, 2004
28. Snanoudj R, Beaudreuil S, Arzouk N, Jacq D, Casadevall N, Charpentier B, Durrbach A: Recovery from pure red cell aplasia caused by anti-erythropoietin antibodies after kidney transplantation. Am J Transplant 4: 274 277, 2004
29. Coronel F, Garcia-Mena M, Martinez R: Pure red-cell aplasia induced by anti-erythropoietin antibodies in peritoneal dialysis. Clin Nephrol 61: 155 158, 2004
30. Shinohara K, Mitani N, Miyazaki M, Sakuragi S, Matsuda K, Ogawara S, Saito T, Kaneoka H: Pure red-cell aplasia caused by the antibody to recombinant erythropoietin, epoetin-beta, in a Japanese patient with chronic renal failure. Am J Hematol 78: 15 20, 2005
31. Wu G, Wadgymar A, Wong G, Ting R, Nathoo B, Mendelssohn D, Pandeya S, Sapir D, Tam P: A cross-sectional immunosurveillance study of anti-EPO antibody levels in CRF patients receiving epoetin alfa in 5 Ontario renal centers. Am J Kidney Dis 44: 264 269, 2004
32. Chang WJ, Tan LK, Liu TC, Ting R, Nathoo B, Mendelssohn D, Pandeya S, Sapir D, Tam P: Cyclosporine treatment for patients with CRF who developed pure red blood cell aplasia following EPO therapy. Am J Kidney Dis 41: 692 695, 2003
33. Cavill I, Williams JD: Benefits of recombinant human erythropoietin. Lancet 360: 1606 1607, 2002